GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $11,490,000 | +107.0% | 168,725 | -2.9% | 4.69% | +113.3% |
Q2 2022 | $5,552,000 | -9.9% | 173,765 | -2.3% | 2.20% | +3.6% |
Q1 2022 | $6,159,000 | +8.6% | 177,789 | -8.3% | 2.12% | +26.2% |
Q4 2021 | $5,672,000 | +13.1% | 193,789 | -1.5% | 1.68% | +12.1% |
Q3 2021 | $5,014,000 | -24.1% | 196,789 | +4.4% | 1.50% | -32.9% |
Q2 2021 | $6,602,000 | -18.4% | 188,508 | -5.1% | 2.24% | -2.3% |
Q1 2021 | $8,095,000 | -14.1% | 198,650 | -8.7% | 2.29% | -12.0% |
Q4 2020 | $9,420,000 | -21.5% | 217,510 | 0.0% | 2.61% | -31.9% |
Q3 2020 | $11,993,000 | -0.2% | 217,510 | +14.3% | 3.83% | -0.5% |
Q2 2020 | $12,019,000 | +24.4% | 190,380 | +0.7% | 3.85% | +1.1% |
Q1 2020 | $9,661,000 | -34.9% | 189,106 | +1.3% | 3.81% | -16.1% |
Q4 2019 | $14,845,000 | +95.8% | 186,756 | +19.5% | 4.54% | +76.9% |
Q3 2019 | $7,581,000 | -8.0% | 156,235 | -0.3% | 2.56% | -1.6% |
Q2 2019 | $8,239,000 | +9.9% | 156,635 | +10.6% | 2.61% | +16.2% |
Q1 2019 | $7,499,000 | +30.8% | 141,685 | +1.4% | 2.24% | +12.7% |
Q4 2018 | $5,734,000 | +16.6% | 139,685 | +7.9% | 1.99% | +48.8% |
Q3 2018 | $4,919,000 | +22.5% | 129,435 | +45.7% | 1.34% | +15.6% |
Q2 2018 | $4,016,000 | +1284.8% | 88,840 | +1380.7% | 1.16% | +1261.2% |
Q1 2018 | $290,000 | +195.9% | 6,000 | +140.0% | 0.08% | +174.2% |
Q4 2017 | $98,000 | – | 2,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |